Lavender (CBD): A Comprehensive Strain Guide

Introduction to Lavender (CBD)

Lavender (CBD) is a balanced, CBD-forward interpretation of the classic Lavender cultivar, designed to deliver the floral, soothing personality of the original with a gentler psychoactive profile. Where the legacy Lavender became known for its linalool-rich bouquet and deeply relaxing indica effects, the CBD-select phenotype shifts the chemistry toward cannabidiol to improve tolerability and broaden therapeutic appeal. In practice, most Lavender (CBD) lots test in the neighborhood of a 1:1 to 1:2 THC:CBD ratio, with total cannabinoids commonly landing between 12% and 20% by dry weight.

The target strain is Lavender (CBD), and it remains one of the more intuitive entry points for consumers exploring non-intoxicating or low-intoxicating flower. Its sensory identity is remarkably consistent: a true lavender, herbaceous aroma layered with sweet spice and gentle earth. That signature is driven by the terpene linalool alongside myrcene, beta-caryophyllene, and limonene, which together impart calm without overwhelming sedation.

Because CBD modulates THC’s effects, Lavender (CBD) often produces a clear-headed, body-easing experience even for those sensitive to THC. Inhale-onset typically appears within 1 to 5 minutes and plateaus by 20 to 30 minutes, with effects tapering after 2 to 4 hours for most users. Edible formats extend onset to 45 to 120 minutes and extend duration to 4 to 8 hours, which suits bedtime or sustained relief scenarios.

History and Evolution

The original Lavender, sometimes referred to as Soma #10, emerged from the Dutch breeding scene in the early-to-mid 2000s. It gained a following for its unmistakable floral profile and richly colored buds, traits that stood out when fuel-forward and citrus-forward genetics dominated menus. As consumer palates matured, Lavender’s unique sensory footprint earned it a cult reputation among connoisseurs and medical patients seeking calm.

The CBD wave reshaped breeding priorities between 2012 and 2016, as high-CBD donors like Cannatonic-type males and CBD-dominant lines became widely used in crosses. Breeders began producing CBD-leaning versions of beloved THC cultivars, and Lavender was a natural candidate due to its linalool-forward bouquet and sedative leanings. Lavender (CBD) selections sought to preserve that aroma while dialing THC down and CBD up to more balanced ratios.

By the late 2010s, several seedmakers were offering "CBD Lavender" or Lavender crossed to CBD-rich parents, stabilizing lines to reliably hit 5% to 12% CBD with enough THC (3% to 9%) to maintain the cultivar’s entourage character. Retail adoption of CBD-rich flower has been modest in THC-centric markets, typically contributing less than 5% of total flower sales volumes in mature U.S. states, but loyal demand persists among wellness users. The result is a niche yet steady presence for Lavender (CBD) in medical dispensaries and boutique adult-use shelves.

Genetic Lineage and Breeding

Classic Lavender’s backbone is often reported as a triad: Super Skunk, Big Skunk Korean, and Afghani Hawaiian. This mash-up integrated resin-heavy Afghan influence with Skunk vigor and a tropical twist, yielding dense, colorful colas with a rich terpene complexion. The CBD reinterpretation typically brings in a high-CBD donor to rebalance the chemotype while preserving Lavender’s floral phenotype.

Breeding methods vary, but a common path is outcrossing Lavender to a CBD-rich parent, then backcrossing and selecting within F2–F4 populations to stabilize a 1:1 or 1:2 THC:CBD ratio. Plants are then stress-tested across environments to ensure the linalool-forward terpene signature holds under different light intensities and nutrient regimes. Marker-assisted selection and targeted chemotyping (e.g., HPLC for cannabinoid acids and GC-MS for terpenes) accelerate this dial-in process.

In stabilized Lavender (CBD) lines, you can expect dominant CBDA and THCA expression alongside secondary cannabigerolic pathways (CBGA). Typical minor cannabinoid presence includes CBC at 0.1% to 0.5% and CBG at 0.2% to 0.8%, depending on environmental stressors and harvest timing. While there is no single universal source lineage for Lavender (CBD), most reputable cuts retain the hallmark lavender-herb spice and purple-ready morphology of the original.

Appearance and Morphology

Lavender (CBD) plants grow with indica-dominant structure: broad leaflets, short internodes, and a medium stature that finishes compact indoors. In veg, plants show dark, glossy foliage with robust lateral branching that responds well to topping and low-stress training. Under cool nights, anthocyanins express as deep violet to plum hues in late flower, especially in upper bracts.

The buds are dense and conical with a high calyx-to-leaf ratio, often finishing in stacked spears that are easy to manicure. Trichome production is generous, with frosted caps covering bract surfaces and sugar leaves; hydrocarbon extractions from well-grown flower commonly return 18% to 22% by weight. Pistils begin a creamy ivory and mature to orange-copper strands that contrast strikingly with purple calyxes.

Average indoor heights settle around 80 to 120 cm (2.6 to 4.0 feet) depending on veg duration, while outdoor plants can finish 150 to 200 cm (5 to 6.5 feet) in temperate climates. Internode spacing tends to be tight, so canopy thinning and selective defoliation improve airflow and reduce botrytis risk in dense late-flower colas. Root vigor is strong in coco and well-aerated organic soils, where plants often exhibit rapid early vegetative growth.

Aroma and Sensory Notes

True to its name, Lavender (CBD) broadcasts a lavender-forward bouquet grounded by herbal and spicy undertones. Freshly ground flower opens with sweet floral top notes, followed by a meadow-like herbality akin to rosemary and thyme. Mid-notes include subtle earth and cedar, with a whisper of vanilla or pastry sweetness in some phenotypes.

Linalool is the aromatic anchor and has been quantified in lavender-leaning cannabis cultivars at 2 to 6 mg/g of dried flower. Myrcene typically supports at 1.5 to 4.0 mg/g, deepening the herbaceous character and augmenting perceived sedative quality. Caryophyllene contributes peppery spice in the 0.8 to 2.0 mg/g range, and limonene brightens the top with citrus lift often measuring 0.5 to 1.5 mg/g.

The nose evolves during cure, increasing sweetness and smoothing rough edges as chlorophyll and green volatiles dissipate. Properly cured Lavender (CBD) retains up to 80% of its terpene load after 30 days when stored in air-tight containers at 16 to 20°C and 55% to 62% relative humidity. Poor storage or high temperatures can halve monoterpene content in weeks, dulling the signature bouquet.

Flavor and Smoke Quality

On inhalation, the flavor mirrors the aroma: lavender blossoms, soft herbs, and a gentle sweetness that rounds the palate. The smoke is typically smooth and medium-bodied, with low throat bite when properly dried to 10% to 12% moisture content and slow-cured for four or more weeks. Exhale brings a peppery-citrus flicker and faint wood that lingers without a harsh aftertaste.

Vaporization at 175 to 185°C maximizes the floral and citrus components by volatilizing linalool and limonene while avoiding terpene degradation. At higher temps (190 to 200°C), the profile leans spicier as caryophyllene and humulene express more fully, with a trade-off in sweetness. Users often report that flavor fidelity from dry-herb vaporizers is superior to combustion, preserving delicate top notes.

In concentrates, particularly live resin or terpene-rich rosin, Lavender (CBD) can taste like a lavender-infused herbal tea with a candied finish. Cartridges formulated from single-strain extracts frequently show total terpene content between 6% and 12%, which maintains strong flavor impact. Terpene reblends should aim to keep linalool dominant to remain faithful to the cultivar’s identity.

Cannabinoid Profile and Ratios

Lavender (CBD) is bred to present a balanced or CBD-dominant chemotype, with most well-grown batches testing total CBD between 6% and 12% by weight. THC generally ranges from 4% to 10%, with the most common target being around a 1:1 ratio (for example, 8% CBD and 8% THC). Total cannabinoids typically sum to 12% to 20%, inclusive of minor constituents.

In raw flower, cannabinoids exist primarily as acidic precursors: THCA and CBDA. After decarboxylation (e.g., heating to approximately 110 to 120°C for 30 to 45 minutes for edibles), a significant portion converts to THC and CBD, respectively. For inhalation, the decarboxylation happens in real-time, which can convert 70% to 90% of acidic cannabinoids to their neutral forms, depending on device and technique.

Minor cannabinoids appear in measurable yet modest quantities. CBG often registers 0.2% to 0.8%, CBC 0.1% to 0.5%, and THCV is usually trace (<0.2%). In 1-gram servings of flower testing 8% CBD and 8% THC, the consumer is effectively inhaling up to 80 mg of CBD and 80 mg of THC before losses; real-world delivery is lower due to combustion and sidestream losses, often approximated at 25% to 40% efficiency.

Terpene Profile and Chemistry

Linalool is the chemotypic hallmark of Lavender (CBD), often topping the terpene list at 2 to 6 mg/g (0.2% to 0.6% by weight). This monoterpene occurs in two enantiomeric forms; the (R)-linalool commonly associated with lavender plants imparts sweet floral notes, while (S)-linalool leans woodsy. Cannabis typically presents a mixed enantiomeric ratio, contributing to a nuanced, layered bouquet rather than a single-note lavender scent.

Myrcene, a frequent co-dominant, ranges from 1.5 to 4.0 mg/g and contributes musky, herbal depth while potentiating perceived sedation. Beta-caryophyllene, at 0.8 to 2.0 mg/g, is unique as a dietary cannabinoid that engages CB2 receptors, potentially mediating anti-inflammatory effects. Limonene, often 0.5 to 1.5 mg/g, sharpens top notes and may elevate mood in synergy with CBD’s anxiolytic profile.

Total terpene content in quality Lavender (CBD) flower typically spans 10 to 25 mg/g (1.0% to 2.5%). Post-harvest handling strongly influences final numbers; drying at roughly 15.5°C (60°F) and 60% RH for 10 to 14 days can retain 60% to 80% of monoterpenes versus fast, warm dries that can cut terpene levels in half. Storage at 4 to 8°C in dark, oxygen-limited containers further slows terpene oxidation over multi-month periods.

Experiential Effects and Onset

Most users describe a relaxed, clear-headed body comfort with minimal mental fog, reflecting the cultivar’s balanced THC:CBD composition. Within minutes of inhalation, muscle tension tends to decompress, and racing thoughts ease without a steep drop into couchlock. The linalool-driven bouquet complements this effect set with a spa-like calm that many find centering rather than sedating.

In consumer feedback, Lavender (CBD) often scores high for stress relief, anxiety soothing, and gentle mood lift. In balanced 1:1 products, studies have noted reduced incidence of THC-induced anxiety and dysphoria versus THC-dominant analogs, consistent with CBD’s dampening effect on CB1-mediated signaling. Duration for inhaled use hovers around 2 to 4 hours, with the peak window between 20 and 60 minutes after onset.

Side effects are typically light and may include dry mouth, slight ocular dryness, and, at higher doses, drowsiness attributed to myrcene and linalool synergy. Individuals extremely sensitive to THC may still notice mild intoxication at ratios near 1:1, though the CBD content usually moderates intensity. Users seeking a purely non-intoxicating effect can target phenotypes or products with 1:2 or 1:3 THC:CBD ratios, lowering psychoactivity further.

Potential Medical Applications

Lavender (CBD) aligns with common therapeutic goals: anxiety reduction, sleep optimization, and relief from inflammatory or neuropathic pain. CBD has demonstrated robust evidence for seizure reduction in certain pediatric epilepsies, with prescription formulations achieving median seizure reductions of roughly 36% to 50% in controlled settings, although Lavender (CBD) is not a substitute for prescribed therapies. In adult-use and medical markets, balanced 1:1 flower is frequently recommended as a starting point for pain and stress because it combines efficacy with tolerability.

Linalool contributes anxiolytic and sedative effects in preclinical models, while beta-caryophyllene’s CB2 agonism suggests anti-inflammatory and analgesic potential. Myrcene may add to analgesia and sleep support, especially in evening use. Users with muscle spasms, tension headaches, or low-grade neuropathic pain often report meaningful relief within 30 to 60 minutes of inhalation.

From a functional perspective, CBD’s interaction with serotonin (5-HT1A) and TRPV1 receptors may underlie some of the anxiolytic and anti-nociceptive benefits. In balanced chemotypes, the presence of THC can enhance analgesia and spasticity relief compared to CBD alone, while CBD tempers adverse psychotropic effects. For daytime use, many patients microdose via vaporization at 2 to 5 mg THC paired with 4 to 10 mg CBD per session to control symptoms without impairment.

Cultivation Guide: Indoors and Outdoors

Lavender (CBD) favors a temperate, low-stress environment with moderate nutrient strength and consistent irrigation. Indoors, expect an 8- to 10-week flowering period (56 to 70 days) from photoperiod flip, with most phenos finishing optimally at 60 to 63 days for a balanced cannabinoid ratio. Indoors under high-efficiency LED at 700 to 900 μmol/m²/s PPFD, yields of 400 to 550 g/m² are achievable with skilled canopy management.

Vegetative growth thrives at 22 to 26°C with 60% to 70% RH and CO2 at 400 to 800 ppm. Flowering targets are 20 to 26°C with RH stepped down from 55% in early flower to 45% by week 6, and 40% in weeks 7 to 9 to mitigate botrytis in dense colas. Maintain pH 6.2 to 6.8 in soil and 5.8 to 6.2 in coco or hydro; electrical conductivity should sit around EC 1.2 to 1.6 in late veg and EC 1.6 to 2.1 in bloom.

Training methods that open the canopy—topping, low-stress training, and screen-of-green—work exceptionally well due to the plant’s lateral vigor. Defoliate selectively at weeks 3 and 6 of flower to improve light penetration and airflow; avoid aggressive leaf stripping that can stall resin production. Maintain 10% to 20% runoff per irrigation in inert media to prevent salt accumulation and keep root zone oxygenation high with frequent, smaller feedings.

Outdoors, Lavender (CBD) finishes by late September to early October in the Northern Hemisphere, with yields of 500 to 800 g per plant in 30- to 50-gallon organic beds. Cool nights in the final three weeks can coax vibrant purples without sacrificing potency; target 10 to 13°C night lows for pronounced anthocyanin expression. Use preventative IPM—sticky cards, weekly scouting, and biocontrols such as Bacillus subtilis for powdery mildew and Beauveria bassiana for soft-bodied pests—to protect dense late-flower colas.

Nutrient Strategy and Irrigation

In soil, a living-organics approach with amended compost, worm castings, and mineral inputs can carry plants through with minimal bottled feeds. Aim for an N-P-K progression roughly centered around 3-1-2 in veg and 1-2-3 in bloom, adjusting for cultivar appetite. Supplement calcium and magnesium at 100 to 150 ppm combined, particularly under high-intensity LEDs.

In coco or hydro, maintain consistent feed at EC 1.3 to 1.5 through mid-veg, increasing to 1.7 to 2.0 in mid-to-late bloom if plants remain dark green and vigorous. Keep root zone temps near 20 to 22°C to at once boost uptake and limit Pythium risk. Lavender (CBD) responds poorly to overwatering; allow 10% to 15% dryback by weight in coco and confirm with pot lift before each irrigation.

Silica at 50 to 100 ppm strengthens stems that carry dense tops, reducing staking needs and wind damage outdoors. Amino chelat